Reata Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Reata Pharmaceuticals

09/08/2021 21:45

* Reata Pharmaceuticals Inc  RETA.OQ  reported a quarterly
adjusted loss of $2.00​​ per share for the quarter ended in
June. The mean expectation of nine analysts for the quarter was
for a loss of $2.06 per share.
* Revenue fell 27.7% to $2.22 million from a year ago;  analysts
expected $1.25 million. 
* Reata Pharmaceuticals Inc's reported EPS for the quarter was a
loss of $2.00​.
* The mean earnings estimate of analysts had risen by about 3.1%
in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Reata Pharmaceuticals Inc shares had fallen by 12.2% this
quarter and gained 0.5% so far this year.
* The company reported a quarterly loss of $72.7 million.
* Wall Street's median 12-month price target for Reata
Pharmaceuticals Inc is $236.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 08:45 p.m.  ​All
figures in US dollars unless otherwise stated